Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivus Inc VVUSQ

Healthcare Biotechnology
VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic... see more

Recent & Breaking News (OTCPK:VVUSQ)

RDInvesting Provides Investors with Free In-Depth Equity Reports on LF, RST, VVUS and YUME

Accesswire September 4, 2013

VIVUS Names New CEO; Incumbent CEO Resigns Due to Health Concerns

Globe Newswire September 3, 2013

New Review Article Discusses Treatment of the Obese Patient in Primary Care

Globe Newswire August 27, 2013

VIVUS Reports Second Quarter and First Six Months 2013 Financial Results

Globe Newswire August 6, 2013

VIVUS Announces Date of Second Quarter 2013 Financial Results and Conference Call

Globe Newswire August 5, 2013

VIVUS Announces Commercial Supply Agreement With Sanofi to Produce Avanafil

Globe Newswire August 1, 2013

VIVUS Board Selects Michael Astrue as Chairman and Tony Zook as CEO

Globe Newswire July 22, 2013

VIVUS, First Manhattan and Sarissa Capital Announce Settlement Agreement

Globe Newswire July 18, 2013

First Manhattan Continues to Seek Fair Settlement

Business Wire July 17, 2013

FMC Rejects Settlement Proposal From VIVUS

Globe Newswire July 17, 2013

VIVUS Identifies False and Misleading Statements Made by First Manhattan Co.

Globe Newswire July 16, 2013

First Manhattan Continues to Seek Settlement Despite Bad Faith Negotiating Tactics from Vivus' Existing Board

Business Wire July 16, 2013

First Manhattan Asks Delaware Court to Certify Results of Vivus' Annual Meeting

Business Wire July 16, 2013

First Manhattan Objects to Adjournment of Vivus Annual Meeting

Business Wire July 15, 2013

First Manhattan Calls Adjournment of Annual Meeting by the Vivus Board a Desperate Act to Disenfranchise Shareholders

Business Wire July 15, 2013

First Manhattan Co.'s False and Misleading Statements Reported to the U.S. Securities and Exchange Commission

Globe Newswire July 14, 2013

VIVUS Extends Invitation to First Manhattan for Three of Their Nominees to Join the Board of Directors

Globe Newswire July 13, 2013

VIVUS Reminds Stockholders to Vote the GOLD Proxy Card by Telephone or Internet Today

Globe Newswire July 11, 2013

Fix Vivus Now - Elect Nine New Independent Directors

Business Wire July 11, 2013

Strong Support for VIVUS's Board and Management Team Among Influential Financial Analysts

Globe Newswire July 10, 2013